Search
Opipramol
go.drugbank.com/drugs/DB12930InvestigationalOpipramol has been used in trials studying the treatment of Dementia, Depression, Schizophrenia, Anxiety Disorders, and Psychosomatic Disorders.
Products: OPHEL 100MG, INSIDON 100MG FTAMineral oil
go.drugbank.com/drugs/DB11057ApprovedInvestigationalVet approvedMineral oil is a common ingredient in baby lotions, cold creams, ointments and cosmetics to treat and prevent dry, rough, scaly, itchy skin and minor skin irritations. … (PAC) can lead to skin cancer.
Mixtures: Minyak Hijau Cap Labu, Mizon Collagenic Aqua Volume Up Li P Essence RenewalCategories: Alimentary Tract and Metabolism, Basic Ointments and ProtectantsCefotetan
go.drugbank.com/drugs/DB01330ApprovedInvestigationalThe drug is highly resistant to a broad spectrum of beta-lactamases and is active against a wide range of both aerobic and anaerobic gram-positive and gram-negative microorganisms. … A semisynthetic cephamycin antibiotic that is administered intravenously or intramuscularly.
Products: Cefotetan and Dextrose, Cefotan Inj 2gm/vialTrastuzumab
go.drugbank.com/drugs/DB00072ApprovedInvestigationalKanjinti (trastuzumab-anns)[L14135] and Hercessi[L52840] are other biosimilars approved by the FDA. In Canada, biosimilars ONTRUZANT[[L40303, L40308] and Adheroza[L52835] are approved. … In November 2023, trastuzumab was also approved by the EMA under the brand name Herwenda.[L49339]
Mixtures: PHESGO® 600MG/600MG, PHESGO® 600MG/600MGCategories: Amino Acids, Peptides, and Proteins, pertuzumab and trastuzumabMidostaurin
go.drugbank.com/drugs/DB06595ApprovedInvestigationalIt was approved on April 28, 2017 and has shown to increase the overall survival rate in patients with AML as an adjunct therapy along with chemotherapeutic agents. … It was initially characterized as a potential broad-spectrum antineoplastic agent, with activity toward diverse solid and hematopoietic tumors [A19108].
Synonyms: 4'-N-benzoylstaurosporineCategories: Antineoplastic and Immunomodulating AgentsDiosmin
go.drugbank.com/drugs/DB08995ApprovedInvestigationalIt is used for the improvement of capillary fragility or venous insufficiency, including chronic venous insufficiency (CVI) and hemorrhoids. … Diosmin is widely available over-the-counter and demonstrates a favourable a favorable safety profile.[A232890,T840,L33040]
Mixtures: Dofomin 500mg Tablet, daflon 500mg tabletsProducts: RUVENTIN FILM COATED TABLET 500MG, FLEBODIA® COMPRIMIDOS RECUBIERTOS CON PELÍCULAEstriol
go.drugbank.com/drugs/DB04573ApprovedInvestigationalVet approvedIt is however available in the United States by prescription filled only by compounding pharmacies. … It has also been approved and marketed throughout Europe and Asia for approximately 40 years for the treatment of post-menopausal hot flashes.
Categories: Genito Urinary System and Sex Hormones, Natural and Semisynthetic Estrogens, PlainProducts: OESTRO GYNAEDRON 1.0MG/G, OEKOLP TABLETTEN 2MGDasatinib
go.drugbank.com/drugs/DB01254ApprovedInvestigational[A2226] The use of dasatinib was first approved by the FDA in 2006.[L45171,L45186] … Dasatinib is an orally available multikinase inhibitor indicated for the treatment of Philadelphia chromosome (Ph)-positive leukemias.
Synonyms: Anh. dasatinib, Dasatinib (anh.)Categories: Antineoplastic and Immunomodulating AgentsPhentermine
go.drugbank.com/drugs/DB00191ApprovedIllicitInvestigationalPhentermine is a sympathomimetic amine anorectic agent and it was introduced in 1959 as part of an anti-obesity combination drug. … This initial product, formed by the combination of phentermine with [fenfluramine] and [dexfenfluramine] was discontinued after finding several reports of abnormal valves in nearly 30% of the consumers
Mixtures: Phentermine and topiramate, Phentermine and topiramateCategories: Alimentary Tract and Metabolism, phentermine and topiramateLetrozole
go.drugbank.com/drugs/DB01006ApprovedInvestigationalLetrozole, or CGS 20267, is an oral non-steroidal type II aromatase inhibitor first described in the literature in 1990. … [A190543,A1559,L11623,L11626] It is a third generation aromatase inhibitor like [exemestane] and [anastrozole], meaning it does not significantly affect cortisol, aldosterone, and thyroxine.
Categories: Antineoplastic and Immunomodulating Agents, Hormone Antagonists and Related AgentsProducts: SOLESTRASA-IN, Van-letrozole